elderly acute myeloid leukemia
Conditions
Interventions
experimental group:Liposomal doxorubicin+ ara-C+ G-CSF
Sponsors
The Second Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients over 60 years who are assessed as ineligible for chemotherapy and there are no limit of gender; 2.Patients who were diagnosed with acute myeloid leukemia (excluding APL) including secondary AML and treatment-realted AML; 3.ECOG score >= 1; 4.The patients themselves or their family members are willing to participate in the study and sign an informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with severe cardiopulmonary or other important organ dysfunction; 2.Patients who cannot comprehend or follow the plan with a brain disorder or serious mental diseases; 3.Patients combined with other malignant tumors; 4.Patients whose necessary treatment plan and follow-up observation cannot be guaranteed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Objective response rate;overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progress free survival;relapse rate; | — |
Countries
China
Contacts
Public ContactZhou Kang
The Second Affiliated Hospital of Chongqing Medical University
Outcome results
None listed